MedPath

Efficacy of Compassion Focused Therapy in Group for Posttraumatic Stress Disorder

Not Applicable
Conditions
PTSD
Interventions
Other: CBT-SG
Other: CFT-G
Registration Number
NCT03154931
Lead Sponsor
University of Sao Paulo General Hospital
Brief Summary

The purpose of this study is to determine the efficacy of a 8-week program of Compassion Focused Therapy in Group comparing to Supportive Cognitive Behavioral Therapy in Group for patients with Posttraumatic Stress Disorder.

Detailed Description

This study will be a randomized clinical trial with two parallel groups, with two models of treatment: Group 1 - Control Group - will receive CBT Supportive Group (CBT-SG) and Group 2 - Experimental Group - will receive Compassion Focused Therapy (CFT-G). Will be attended in total, the maximum of 80 patients, with 40 patients in each arm (CBT-SG versus CFT-G). Both groups will be formed by at least eight patients and a maximum of twelve patients who receive eight weekly sessions with an hour and a half each session, and the total duration of treatment will be eight weeks. The groups will be closed, that is, after the start will not be permitted to input any more participants. The experimental group (CFT-G) will be structured and the control group (CBT-SG) will be unstructured, and free format.

All patients will be assessed through self-report scales, within three distinct phases: Assessment I - Initial (before therapy); Assessment II - Final (after therapy); Assessment III - Follow-up (after 3 months of therapy ending).

All groups will be led by a principal therapist and co-therapist. All sessions will be recorded for later evaluation of the researcher responsible for the research.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Clinical Administered PTSD Scale 5 Monthly version Criteria A and >30 points
Read More
Exclusion Criteria
  • Suicidal patients and/or severe automutilation behavior and/or psychotic symptoms and/or lack of event memory.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CBT-SGCBT-SGThis CBT-Supportive group will focus on the interaction here-and-now, realizing that the group acts as a secure place, driven by interactions among its participants and therapist and co-therapist. The main objective is to welcome and support the participation of all patients and stimulate the group's initiatives, encouraging interpersonal interactions and mutual aid. There will be no specific therapeutic intervention in relation to any PTSD related content.
CFT-GCFT-GThis CFT-group will focus on activities using specific therapeutic strategies, to learn and training compassionate skills - psychoeducation and exercises developed for use in session and at home.They will learn What is compassion and shame? Steps to the training of compassion and how Building a compassionate image. Will use Thoughts Daily Record - self critical and self compassionate. Explanation of Formulation of Strategy Threats and Security, The Three Emotional regulation systems and PTSD formulation - based on shame and guilt. They will learn how to incorporate these skills to everyday situations. At the end, will write an Autobiography writing about this experience and share with the group.
Primary Outcome Measures
NameTimeMethod
Clinical Administered Posttraumatic Stress 5up to 8 weeks

40% decrease

Secondary Outcome Measures
NameTimeMethod
Self Compassion Scaleup to 8 weeks

50% increase

Davidson Trauma Scaleup to 8 weeks

40% decrease

Beck Depression Inventoryup to 8 weeks

final rating \<20.

Beck Anxiety Inventoryup to 8 weeks

final rating \<19.

Beck Hopelessness Scaleup to 8 weeks

final rating \<9.

Other as a Shame Scaleup to 8 weeks

50% decrease

Functions of Self Critical Scaleup to 8 weeks

50% decrease

Connor Davidson Resilienceup to 8 weeks

50% increase

Outcome Questionnaire 45up to 8 weeks

50% decrease

Trial Locations

Locations (1)

AMBAN - Anxiety Program at IPQ-HCFMUSP

🇧🇷

Sao Paulo, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath